Ghrelin hormone "can boost resistance" to Parkinson's

Healthcare News
27/11/2009
Ghrelin can boost a person's resistance to Parkinson's disease, it has been discovered.

The importance of dopamine in regards to Parkinson's disease has been addressed by researchers in the US.

It is a widely-held understanding that the degeneration of dopamine neurons in an area of the brain known as the substantia nigra - which is responsible for dopamine production - leads to a worsening of conditions.

This can lead to an increased difficulty in walking, restricted movements, a lack of appetite, periods of motionlessness and notable head and limb tremors, according to scientists on the project at the Yale School of Medicine.

Tamas Horvath, the chair of the facility and professor of comparative medicine, explained that he and his team discovered that ghrelin is responsible for directly activating the brain's dopamine calls.

He continued: "Because this hormone originates from the stomach, it is circulating normally in the body, so it could easily be used to boost resistance to Parkinson's or it could be used to slow the development of the disease."

Earlier this month, it was discovered that red tomatoes contain a lot of ghrelin, as well as making a person feel fuller quicker.

Please click here for advice to help you find the right type of care.ADNFCR-504-ID-19482845-ADNFCR

News Search

Related News

Tests to begin on Parkinson's disease drug
02/09/2010
The effectiveness of a new Parkinson's disease drug is to be examined in a new test at University College London.

Charity claims victory in Parkinson's drug campaign
23/08/2010
A drug for treatment of Parkinson's disease will be made more widely-available, following a charity campaign.

Scientists claim Parkinson's disease breakthrough
17/08/2010
The use of human stem cells in rodents has managed to reverse the symptoms of Parkinson's disease, it is claimed.

Canadian scientists create 'brain on a microchip'
16/08/2010
New technology developed in Canada will help scientists to understand how Parkinson's disease works.

View all news